High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimination

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Egyptian Patients

Review for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v1/review1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

Risk prediction for delayed clearance of high-dose methotrexate in pediatric hematological malignancies by machine learning

International Journal of Hematology ◽

10.1007/s12185-021-03184-w ◽

2021 ◽

Author(s):

Min Zhan ◽

Zebin Chen ◽

Changcai Ding ◽

Qiang Qu ◽

Guoqiang Wang ◽

...

Keyword(s):

Machine Learning ◽

Risk Prediction ◽

High Dose ◽

High Dose Methotrexate ◽

Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies

Hematological Oncology ◽

10.1002/hon.2759 ◽

2020 ◽

Vol 38 (4) ◽

pp. 584-588

Author(s):

Irina Amitai ◽

Uri Rozovski ◽

Reem El‐Saleh ◽

Shai Shimony ◽

Daniel Shepshelovich ◽

...

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

Decision letter for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v2/decision1 ◽

2020 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

ABCL-030: Safety of Ambulatory High-Dose Methotrexate (HDMTX) Administration Among Hematological Malignancies Patients in a Tertiary Care Center

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01862-0 ◽

2021 ◽

Vol 21 ◽

pp. S378

Author(s):

Ibrahim Motabi ◽

Maged Al-Ammari ◽

Belai Albtoosh ◽

Abdullah Alrajhi ◽

Fouad Alnajjar

Keyword(s):

Care Center ◽

Tertiary Care ◽

High Dose ◽

High Dose Methotrexate ◽

Tertiary Care Center ◽

Review for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v1/review2 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

Decision letter for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v4/decision1 ◽

2020 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

Review for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v3/review1 ◽

2020 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

Decision letter for "Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies"

10.1002/hon.2759/v3/decision1 ◽

2020 ◽

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Kidney Injury ◽

High Dose ◽

High Dose Methotrexate ◽

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1751-4 ◽

2011 ◽

Vol 69 (3) ◽

pp. 691-696 ◽

Cited By ~ 28

Author(s):

Patrizia Chiusolo ◽

Sabrina Giammarco ◽

Silvia Bellesi ◽

Elisabetta Metafuni ◽

Nicola Piccirillo ◽

...

Keyword(s):

Adult Patients ◽

High Dose ◽

High Dose Methotrexate ◽

Dose Methotrexate ◽

Leucovorin Rescue